MedTrace Logo

A New Flexible Extended-Length Pharyngeal Airway for Deep Sedation

NCT04419883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2020-06-09

No results posted yet for this study

Summary

The purpose of this prospective pilot provider adoption study was to evaluate user experience a new airway device in adult patients with airway obstruction under deep sedation. Fifteen hospital systems served as testing sites. Fifty-four anaesthetist providers reported their experience with the airway device in 84 cases across two phases of surveying.

Conditions

  • Upper Airway Obstruction

Interventions

DEVICE

McMurray Enhanced Airway

Provider Satisfaction of a New, Flexible Extended-Length Pharyngeal Airway to Relieve Upper Airway Obstructive During Deep Sedation: A Pilot Study

Sponsors & Collaborators

  • McMurray Medical Group, LLC

    lead INDUSTRY

Principal Investigators

  • Roxanne McMurray, DNP · McMurray Medical Group, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-05
Primary Completion
2020-03-05
Completion
2020-05-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04419883 on ClinicalTrials.gov